Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
Hematologic Oncology Update
00:00
Case 4: retreatment after venetoclax‑obinutuzumab
She notes venetoclax retreatment can work if prior remission lasted >2 years; research is ongoing on repeat fixed‑duration therapy.
Play episode from 44:53
Transcript
